| Ytd | 70.79% | |
| 1y | 292.88% |
| Open | 55.76 | Prev Close | 55.06 | Low | 53.71 | High | 55.76 | Mkt Cap | 1.63B |
| Vol | 868.85K | Avg Vol | 585.98K | EPS | -1.02 | P/E | N/A | Forward P/E | 10.54 |
| Beta | 0.41 | Short Ratio | 14.67 | Inst. Own | 106.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-21 | 50-d Avg | 56.33 | 200-d Avg | 47.72 | 1yr Est | 89.63 |
TD Cowen analyst Joseph Thome maintains AnaptysBio (NASDAQ:ANAB) with a Buy and lowers the price
HC Wainwright & Co. analyst Joseph Pantginis reiterates AnaptysBio (NASDAQ:ANAB) with a Buy a